Therapeutic intervention for the post-stroke hemiplegic with spastic hypertonia must be individualized to the patient's needs, but generally includes frequent range of motion. Therapeutic exercise, cold, or topical anesthesia may decrease reflex activity for short periods of time in order to facilitate minimal motor function. Casting and splinting techniques are extremely valuable to extend joint range diminished by hypertonicity. Dantrolene sodium is the pharamacologic agent of choice in the United States for the treatment of spastic hypertonia due to stroke. It is the only available drug that acts directly on muscle tissue. Peripheral electrical stimulation may have limited use in diminishing tone and facilitating paretic muscles. Phenol injections provide a valuable transition between short-term and long-term treatments, and offer remediation of hypertonia in selected muscle groups. Tenotomies and tendon transfers offer significant benefit in carefully chosen stroke patients, and the "SPLATT" procedure is one of the most successful rehabilitative surgeries. Achilles Tendon lengthening and release of long toe flexors may complement the SPLATT procedure in the management of the hemiplegic with spastic equinovarus. Key Words: muscle hypertonia, muscle spasticity, brain injury, stroke, neuropharmacology.
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Spasticity is one of the most important impairments for patients following stroke. Any professional caring for the cerebrovascular hemiplegic is familiar with the common synergic patterns of flexion in the upper extremity and extension in the lower. Before treatment is initiated, however, the physician needs to address several important questions. Is there a functional impairment due to the spastic hypertonia? How is gait disturbed? Does the pain that can be associated with &dquo;spasms&dquo; disturb the patient's sleep? Is the lower extremity extensor tone useful to the patient in supporting him during his gait pattern? A stereotyped therapeutic approach has been proposed (1), but as in many aspects of neurological rehabilitation, treatment is best individualized to a particular patient (2) . A daily stretching program is an integral component of any management program for spastic hypertonia. A common bedside observation is that resistance progressively diminishes as one continuously ranges a limb and repeats the motion. Regular ranging of a patient's limbs helps prevent contractures, and can reduce the severity of spastic tone for several hours. The reasons for this &dquo;carry over&dquo; of ranging are not completely clear, but could be related to mechanical changes in the musculotendinous unit, as well as to plastic changes within the central nervous system. These plastic events may correlate with short-and long-term modulation of synaptic efficacy associated with neurotransmitter changes on a cellular level. Habituation of reflex activity has been studied in the marine snail Aplysia californica, which has a simple nervous system. The snail has a reflex for withdrawing its respiratory organ and siphon that is similar to the leg-flexion withdrawl reflex in humans. Repetitive activation results in a decrease in synaptic transmission, partly due to an inactivation of calcium channels in the presynaptic terminal. The decrease in calcium influx diminishes the release of neurotransmitter, probably due to the calcium-dependant exocytosis of neurotransmitter vesicles (3, 4 ).
Short-term Strategies.
Certain interventions may be valuable as temporizing strategies when a specific goal is in mind. Several schools of therapeutic exercise have suggested that reflex-inhibiting postures may temporarily decrease spastic hypertonia so that underlying movements may be unmasked (5,d,~. Utilizing these strategies, therapists are able to help hemiplegic stroke patients produce voluntary movements.
Topical cold has been reported to decrease tendon reflex excitability, reduce clonus, increase range of motion of the joint, and improve power in the antagonistic muscle group. These effects can be used to facilitate improved motor function for short periods of time (7) (8) (9) (10) (11) (12) (13) (14) . Tone may be decreased shortly after the application of ice, probably due to decreased sensitivity in cutaneous receptors and slowing of nerve conduction. Central factors such as changes in central nervous system excitability may take longer to occur. Thus a therapist might apply a cold pack for twenty or more minutes to obtain maximum effect (15) .
Topical anesthesia may have similar effects (16, 17) .
Casting and splinting techniques can improve the range of motion in a joint due to hypertonic contracture, and positioning the limb in a tonic stretch decreases reflex tone (18) (19) (20) (21) (22) (23) (24) (25) . In one study, long-term but not short-term casting resulted in a significant decrease in both dynamic and static reflex sensitivity. Elongation of the series elastic component of the ' musculotendinous unit and an increase in the number of sarcomeres within muscle fibers may each have contributed to the decrease in tone (26) . Biofeedback techniques have also been observed to modulate spastic hypertonia, but have not demonstrated much widespread usefulness (27) (28) (29) .
Pharmacologic Intervention (2, 30, 31) No medication has been uniformly useful in the treatment of spastic hypertonia. Considering the variety of problems associated with spasticity after stroke, it is unlikely that one agent will be beneficial to all parties. More importantly, all drugs have potentially serious side effects, and these negative features should be carefully weighed when beginning a patient on any drug. Continued use of a drug should be contingent on a clearly benefitial effect.
Baclofen (Lioresals) is an analog of gamma-Plianitacologic Treatment of Spastic Hypertonia * Half-life of active primary metabolite is significantly longer aminobutyric acid (GABA), a neurotransmitter involved in presynaptic inhibition. Badofen does not bind to the the classical GABA &dquo;A&dquo; receptor, but rather to a recently discovered and less wellcharacterized &dquo;B&dquo; receptor. Agonism at this site inhibits calcium influx into presynaptic terminals, and suppresses release of excitatory neurotransmitters (31) . Baclofen inhibits both mono-and polysynaptic reflexes, and also reduces activity of the gamma efferent (32) . Although therapeutic effects in spinal lesions occur when plasma levels exceeded 400 ng/ml (33) , optimal responses have been obtained at very different plasma and cerebrospinal fluid levels (34) . Baclofen is completely absorbed after oral administration, and is eliminated predominantly by the renal route. Its half life is approximately 3.5 hours. Baclofen readily crosses the blood-brain barrier, in contrast to GABA (35, 36) .
While baclofen is probably the drug of choice in spinal forms of spasticity (37, 38) , its role in the treatment of spasticity after stroke remains unsettled (32, 39, 40) . It may interfere with attention and memory in brain-injured patients (41) . Baclofen may improve bladder control by decreasing hyperreflexive contraction of the external urethral sphincter (42) , and has been shown to be safe and effective in longterm use (43) . Dosage begins at approximately 5 mg po BID-TID, and may be slowly titrated upwards towards a recommended maximum dose of 80 mglday. This &dquo;recommended maximum dose&dquo; may not necessarily be the most effective dose for the patient, however, and higher doses may be well-tolerated as well as additionally therapeutic (44, 45) . There is a low incidence S7 of side effects, which may include hallucinations, confusion, sedation, hypotonia and ataxia (39, 46) . Sudden withdrawl of the drug may lead to seizures and hallucinations (47) . Stereospecific L-baclofen is more effective than the presently used racemic form in treatment of pain (48, 49) . Baclofen deserves evaluation for treatment of spastic hypertonia.
Diazepam (valium) facilitates postsynaptic effects of GABA, resulting in increased presynaptic inhibition (50) . It has no direct GABA-mimetic effect, but exerts indirect mimetic effect only when GABA transmission is functional (30) . In addition to its known effects in the brain (51) , it has some effect in patients with demonstrated spinal cord division (52), although its effect in complete spinal lesions was not confirmed in one report (53) .
Diazepam is generally unsuitable'for use in stroke patients due to deleterious effects on attention and memory (54) . Other side effects include intellectual impairment and reduced motor coordination.
Evidence of abuse and addiction is rare, but true physiologic addiction may occur. Withdrawal symptoms may appear if diazepam is tapered too rapidly. There is some synergistic depression of the central nervous system when administered with alchohol.
Although the potential for overdose exists, the benzodiazepines have an extremely large index of safety (55) . Dosage begins at approximately 2 mg po BID, and may be slowly titrated up to 60 mg or more per day, in divided dosages.
Dantrolene sodium (DantriumO) reduces the muscle action potential-induced release of calcium into the sarcoplasmic reticulum, decreasing the force produced by excitation-contraction coupling (56) . Thus, dantrolene &dquo; is the only drug which intervenes in spastic hypertonia at a &dquo;muscular&dquo; rather than a segmental reflex level. It reduces the activity of phasic greater than tonic stretch reflexes (57) . Dantrolene affects fast muscle fibers greater than slow ones, and, for unknown reasons, seems to have little effect on smooth and cardiac muscle tissues. It is metabolized largely in the liver, and eliminated in urine and bile. Its half-life is 8.7 hours (57).
Dantrolene is the preferred agent for spastic hypertonia after stroke (58) . The patients who may benefit the most are those with emerging motor control which is limited by severe hypertonia. It is less likely to cause lethargy or cognitive disturbances than baclofen or diazepam (54) . Although dantrolene theoretically &dquo;weakens&dquo; muscles, the effects on spastic hypertonia are generally not accompanied by impairment of motor performance. Its most pronounced ' effects may be a reduction in clonus and muscle spasms resulting from innocuous stimuli (59) .
Dantrolene is mild to moderately sedative, and may cause malaise, nausea and vomiting, dizziness, and diarrhea. Its most commonly considered side effect is hepatoxicity, which may occur in 2% of patients. Generally, liver function tests are monitored periodically, and the drug can be tapered or discontinued if enzyme elevations are noted. Fatal hepatitis has been reported in 0.1-0.2%a of patients treated for longer than sixty days (44) . Dosage begins at 25 mg per day and may slowly increase up to 400 mg/day (57) . Clinical results are not clearly related to dose, and may plateau at a dosage of 100 mg/day (60) . Tizanidine is not presently approved for use in the United States. It is an imidazoline derivative that is gaining increasing use outside of the United States, and has an agonistic action at central alpha-2 adrenergic receptor sites. It may facilitate the action of glycine, an inhibitory neurotransmitter (61) , and prevents the release of excitatory amino acids, i.e. L-glutamate and Lraspartate, from the presynaptic terminal of spinal intemeurons (62) . It reduces tonic stretch reflexes and enhances presynaptic inhibition in animals. It also enhances vibratory inhibition of H reflex and reduces abnormal co-contraction (63) . Tizanidine has the unusual effect of increasing the torque of spastic muscle by increasing the amplitude of the agonist EMG signal (64) . It is equivalent to baclofen as an antispastic agent but may be better tolerated in divided dosages up to 36 mg/day (61, 65) . It has similarly been shown to be equally efficacious and better tolerated than diazepam in patients with chronic hemiplegia (66) . Common side effects include mild hypotension, sleepiness, weakness and dry mouth (67) . Both tizanidine and baclofen are more effective in extensor than flexor musculature (68) .
Electrical Stimulation
The use of electrical stimulation to improve patient function, or &dquo;functional electrical stimulation,&dquo; has received wide medical and lay press. Cyclical use of electrical stimulation decreases upper extremity contractures (69) improves motor activity in agonistic muscles, and reduces tone in antagonistic muscle groups of the hemiplegic and quadriplegic patient (69) (70) (71) (72) (73) . In a carefully performed study, stimulation of the sural nerve, a flexor reflex afferent, decreased extensor tonus and increased the strength of ankle dorsiflexion (74) . These therapeutic effects may last for an hour or more after stimulation has been discontinued (75) (76) (77) , perhaps due to neurotransmitter modulation within the segmental reflex. Peroneal nerve stimulation may suppress ankle clonus in ambulatory hemiplegic patients via reciprocal inhibition (78) . Electrical stimulation has limited but defined applications as a dorsiflexor-assist during hemiplegic gait, and as a hand-opening educational device in the plegic upper extremity (79, 80) .
Phenol Injections
Nerve and motor point blocks with injectable phenol offer the physician a somewhat effective method of reducing spastic tone on a local albeit temporary basis. Two to six per cent aqueous phenol solutions produce chemical neurolysis when applied to a nerve trunk or its terminal nerve fibers (motor point block) (81) (82) (83) (84) (85) (86) (87) (88) . Concentrations of phenol greater than 5% cause protein coagulation and necrosis. Neurolysis of motor points are generally ineffective by themselves, perhaps due to the multiplicity of motor points within a muscle (89) . Nerve blocks may be quite effective, and may last three to six months or more (82, 84, 85, 90) .
Musculocutaneous blocks can be helpful in the hemiplegic with severe elbow flexion contracture (90) . Elbow flexion is preserved through the action of the brachioradialis muscle, which, unlike other elbow flexors, is innervated by the radial nerve. Median nerve blocks help relax tightly contracted hemiplegic wrist and fingers. Tibial nerve block can reduce severe equinovarus ankle posturing (83, 87) . A preliminary diagnostic block with local anesthetic is often useful to predict the effect of a longer-acting phenol procedure. Implantable reservoirs can be used to repeatedly inject long-acting anesthetic agents onto the brachial plexus in hemiplegics with severely spastic upper extremities (91) .
Nerve blocks may be associated with dysesthesias and causalgia in approximately 10% of patients; the patient should be advised of this before the block is administered (86) . Severe persistent dysesthesias may be treated with oral steroids or repetition of the phenol block (92) . Open phenol nerve blocks may be more successful, by selectively blocking fibers destined for muscle groups, while leaving sensory fibers unharmed. Presumably, the incidence of dysesthesias should also be lower using this method (90) . Venous thromboses may complicate phenol injection for chemical neurolysis (93) .
Botulinum toxin injection to weaken muscle is a procedure that may complement or supplant the phenol nerve or motor point block. Botulism toxin has been used investigationally for many years in the treatment of ocular muscle disorders such as blepharospasm and strabismus. It has also been used ina variety of other dystonias including torticollis and hemifacial spasm. Type A toxin produced by Clostridium botulinum produces an irreversible block-ade of cholinergic junctions at the motor endplate by inhibiting the release of acetylcholine, functionally denervating the muscle. It awaits evaluation in the treatment of spastic hypertonia (94) .
Orthopaedic Procedures
Tenotomy, the release of a tendon to a severely hypertonic muscle, is a more advanced treatment that may provide benefit in selected patients. Selective quadricep release may help those patients that suffer from a stiff-legged gait. Out-of-phase firing of the rectus femoris and vastus intermedius are the most common cause of such a gait deviation (95) . Achilles tenotomies are a valuable asset in many patients with plantar flexion contractures which interfere with functional goals. Although various methods of lengthening the heelcord exist, it is generally conceded that an open procedure is desirable for precision. Toe flexor tenotomies may be benefitial in the hemiplegic patient when hypertonicity of the foot intrinsics result in claw foot type deformities (96) .
Tendon transfer in various upper extremity muscle groups has been suggested for the augmentation of motor function in hemiplegic individuals (97) . Transfer of the flexor digitorum sublimis to the profundus, brachioradialist transfer to the long finger extensors (98) , and fractional lengthening of long flexors have been advocated in stroke patients (99) , but it is not universally accepted that these procedures improve the patient's functional activities. Overlengthening of the finger flexors can result in a loss of grip strength (100) . Adequate sensory function must be present before any type of upper extremity surgery is contemplated. V-Y lengthening of the triceps muscle has been advocated in the occasional hemiplegic in whom severe triceps tone limits function (101) . The marked complexity of upper extremity function limits the use of transfer surgery in that limb, since patients tend to perform activities of daily living with the remaining functional extremity.
Lower extremity tendon transfer is undoubtably the most successful and useful type of rehabilitative surgery in the hemiplegic patient, and is used for the remediation of equinovarus posturing. The SPLATT Procedure-split anterior tibial transfer-helps to reduce excessive supination at the subtalar joint. The tibialis anterior tendon is split along its length, and the distal end of the lateral half is tunneled into the . third cuneiform and cuboid bones. This creates an eversion force which is slightly greater than the varus pull of the remaining medial portion. It is generally performed in combination with an Achilles Tendon lengthening (102) . The SPLATT Procedure is one of S9 the most useful types of hemiplegic rehabilitative procedures, and may substantially improve affected gait (103, 104) .
